Business News

Business

Biogen Reports a 6% Revenue Growth to $2.4 Billion in Q1 2025, Signaling Strong Market Position

Biogen Inc. reports a 6% revenue growth to $2.4 billion in Q1 2025, with a notable shift in revenue sources outside its MS business, despite a decrease in GAAP earnings per share.

Business

McDonald's Q1 2025 Financial Report: A 3% Revenue Dip to $5.9 Billion Sparks Market Reactions

McDonald's reports a 3% revenue decline in Q1 2025, with earnings per share and operating income also down. CEO Kempczinski remains confident in the brand's resilience and market p...

Business

Eternal Ltd's Stunning 78% Profit Plunge to Rs 39 Crore Amidst a 64% Revenue Boom in Q4

Eternal Ltd, previously Zomato, faces a 78% profit drop to Rs 39 crore in Q4 2025, despite a 64% revenue increase to Rs 5,833 crore, with Blinkit's losses widening and strategic ac...

Business

Deloitte Forecasts India's Economy to Grow 6.6% in FY26 Despite Global Trade Hurdles

Deloitte forecasts India's economy to grow by 6.6% in FY2025-26, balancing domestic stimulus against global trade challenges. Despite a Q3 slowdown, resilience is shown with a 9.2%...

Business

Linde Holds Steady with $8.1 Billion Sales in Q1 2025 Amid Mixed Regional Performance

Linde plc reports steady Q1 2025 sales at $8.1 billion, with a 5% rise in diluted earnings per share. Mixed regional performance noted, with growth in the Americas but declines in ...

Business

CVS Health Reports a 7% Revenue Surge to $94.6B in Q1 2025, Shares Jump 4.79%

CVS Health Corporation reported a 7% increase in Q1 2025 revenue to $94.6 billion, with net income rising to $1.78 billion. The company revised its full-year cash flow guidance dow...

Business

General Motors Faces $5B Tariff Challenge, Revises 2025 Profit Outlook Downward

General Motors has lowered its 2025 earnings forecast due to $5 billion in exposure from US tariffs, with adjusted profits expected between $10 billion and $12.5 billion. CEO Mary ...

Business

Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales

Moderna reports a $1 billion net loss in Q1 2025 due to decreased COVID-19 vaccine sales, with Spikevax® generating $84 million. CEO Stephane Bancel remains optimistic about future...